ITC Program Highlights and Overview

Over 300 faculty have been selected and invited by the Program Organizing Committee (POC) to give talks at the ITC. We have a sampling of the ITC Meeting program highlights to share with you and we invite you to review the entire program at www.ITC2015.thyroid.org: The ITC Welcome Ceremony and Opening Session on Sunday evening at 5:15 pm will address “Progress in Thyroid Research: Highlights from the Last Decade” presented by internationally recognized thyroidologists in 4 topic areas. Sandra McLachlan on Autoimmunity; Martin Schlumberger on Thyroid Cancer Neoplasm; Douglas Forrest on Thyroid Hormone Action; and, David Cooper on Clinical Thyroidology.

The early-riser symposium on Monday morning will focus on New Modalities to Treat Medullary Thyroid Cancer (MTC) with a focused discussion on molecular mechanisms (Rui M.B. Maciel), targeted therapeutic agents (Rossella Elisei), side effects management of long-term TKI treatment (Barbara Jarzab) and an update on the MTC guidelines (Sam Wells). The morning continues with the Opening Plenary Session: Advancing Individualized Medicine with Public-Private Partnerships delivered by Bill Chin.

On Tuesday, the plenary will be delivered by Luigi Bartalena on the Choice of Therapy for Graves’ Hyperthyroidism. In addition, results of 2 recently published trials of rituximab for the treatment of Graves’ orbitopathy will be discussed by the authors.

An innovative program of Discussion/Debates will be offered each day from Monday – Thursday. Look for the variety of topics, such as:

  • TSH Reception Activation and Its Impact on Body Composition and Graves’ Orbitopathy – Marian Ludgate and Lei Zhang
  • Maternal Hypothyroxinema – What Do We Know and What Don’t We Know – Marco Medici and Chrysoula Dosiou
  • Is it Possible to Improve Outcomes in Congenital Hypothyroidism? – Stephen H. LaFranchi and Tone Torresani
  • Debate: Emerging Concepts In The Management Of Recurrent Thyroid Cancer – Ian D. Hay and Enrico Papini
  • Deiodinase and Cancer – Stephen A. Huang and Domenico Salvatore
  • Novel techniques in the Study of Thyroid Autoimmunity: TSHR Crystallography – Jane Sanders and Ricardo Núñez Miguel
  • Management of Thyroid Storm – Henry B. Burch and Tetsurou Satoh
  • Vertebrate Models for Study of TH Action – Luca Persani and Yun-Bo Shi
  • Core and Fine Needle Biopsy: Pros and Cons – Jung Hwan Baek and Teresa Cristina Santos Cavalcanti
  • Thyroid Function and Metabolic Syndrome – Gabriela Brenta and Jiajun Zhao
  • Pharmacologic and Destructive Therapy for Benign Nodules – Laszlo Hegedus and Jeong Hyun Lee
  • New Molecular Drivers In Thyroid Cancer – Mingzhao Xing and Minho Shong
  • Interaction between Autoimmunity and Thyroid Nodules – Bingyin Shi
  • Controversies in Treatment of Graves’ Disease in Children – Scott Rivkees and Juliane Leger
  • Optimal Imaging for Thyroid Cancer – Ultrasound: Jin Young Kwak and Scintigraphy: Markus Luster

Wednesday’s early riser symposium is New Development in Thyroid Surgery: Nerve Monitoring (Kersten Lorenz), Remote Access Thyroid Surgery (Woong Youn Chung) and Predictors of Hypoparathyroidism (Saba Balasubramanian). And on Friday morning, there will be a Plenary lecture on Progress in the Surgical Management of Neoplasia and Hyperthyroidism by Sally Carty.

To maximize understanding of maternal and child thyroid health, the ITC will offer symposia on a wide-range of related topics. On Tuesday, look for the symposium on Fetal Thyroid/Pituitary/Hypothalamic Programming in Maternal Thyroid Disease: Thyroid Hormone and Brain Development (Juan Bernal), Brain Morphological Changes in Children Born to Mothers with Hypothyroidism (Georg Brabant); Neurodevelopmental Disorders in Children Born to Mothers with Thyroid Dysfunction: Clinical Follow-up Studies in Support of Fetal Programming (Stine Linding Andersen). On Thursday morning, the plenary lecture will be given by Samuel Refetoff on Congenital Thyroid Disorders.

Complex ethical issues involved in clinical thyroidology will be presented concerning the management of Anaplastic Thyroid Cancer in Oregon and The Netherlands; Thyroid Cancer Pre-Vivors: A New Global Patient Population and Global Health Disparities in Thyroidology: A Distributive Justice Problem, moderated by Valéria Guimarães.

The Thursday early riser is an Update on Differentiated Thyroid Cancer – Molecular Mechanisms and Treatment with a balance of relevant short lectures: Altered Signal Transduction Pathway (Haixia Guan), Targeting Thyroid Cancer Microenvironment (Laura Ward), Single vs Combination Therapy (Marcia Brose), Update on Differentiated Thyroid Cancer Guidelines (Matthew Ringel).

We wrap up the ITC with one of our most highly rated sessions: the Thyroid Cancer Tumor Board, moderated by Bryan Haugen with speakers from the following disciplines:

  • Surgery
  • Nuclear Medicine
  • Endocrinology
  • Pathology
  • Radiation Oncology
  • Medical Oncology

In addition to this rich and diverse scientific program, the POC has designated topics which can be discussed from clinical, basic and translational perspectives for symposia to be offered twice each day (4 concurrent sessions), except for Tuesday when the dayends early for participants to enjoy local attractions including the Tuesday night 15th ITC social reception at EPCOT®. A focus throughout the meeting will be to discuss recent biomedical advances and translate research from the bench to their broader clinical applicability.

Sister Society Benefits and Logistics

  • Members of each co-sponsoring society (ATA, AOTA, ETA, LATS) will be able to register at the member rate.
  • Trainees from each co-sponsoring society will be able to attend the Ridgway Trainee Conference.
  • Each society will have a reserved meeting room throughout the ITC in the headquarters’ hotel for Governance and Business.

Abstract Submission

Abstracts may be submitted for consideration as a: (1) Poster, (2) Oral Abstract Presentation, or (3) Posters with Short Oral Presentation. When submitting your abstract, please make sure to select which presentation method you want to be considered. Highly scored abstracts submitted will be accepted for oral presentations (12-minute presentations with 1-2 minutes for discussion) or posters with short oral presentations (poster plus one slide with maximum 5-minute presentation). All other abstracts will be considered/accepted for poster presentation. Once notifications are released, all submitters will be provided with a deadline to respond regarding acceptance of abstract placement (poster, oral or poster for short oral discussion). Six (6) Short Call Abstracts will be selected for 10-minute oral presentations during a special symposium. Selected additional short call abstracts may be presented as special posters. All other submissions will not be published.

ABSTRACT SUBMISSION CATEGORIES

Clinical or basic/translational abstracts may be submitted in the

following categories:

  • Autoimmunity
  • Disorders of Thyroid Function
  • Iodine Uptake and Metabolism
  • Thyroid and Development
  • Thyroid Cancer
  • Thyroid Hormone Action
  • Thyroid Hormone Metabolism and Regulation
  • Thyroid Imaging
  • Thyroid Nodules and Goiter

Chester Ridgway Trainee Conference

The ATA is pleased to announce that the 2nd Annual E. Chester Ridgway Trainee Conference (Ridgway) will begin on Sunday, October 18, 2015 and continue through the 15th International Thyroid Congress (ITC). Replacing the previously named ATA Trainees’ Track and Endocrine Fellows Conference, the Ridgway includes exciting new components with the overall objective of advancing the trainee understanding of thyroid physiology, disease and treatment.

The ATA E. Chester Ridgway Trainee Conference is named in memory of Dr. E. Chester (Chip) Ridgway who founded and organized the Endocrine Fellows’ Conference (EFC) for 20 years. The EFC program educated over 1500 fellows, many of whom have become leaders in the thyroid field. A record number of 230 trainees participated in the inaugural Ridgway Trainee Conference in 2014. Fellows, residents, postdocs, and students came from 21 countries to participate in this career developing opportunity.

The Ridgway is comprised of special accredited sessions each day of the 15th ITC specifically designed to enhance the “trainee experience.” The first day of the Ridgway Trainee Conference on Sunday, October 18 kicks off with a full-day of unopposed sessions for trainees in clinical and surgical arenas from 8:00 am – 4:30 pm. The Ridgway continues Monday, October 19th through Thursday, October 22nd with sessions taking place throughout the day for clinical, basic and surgical trainees running in parallel and in concert with the 15th ITC scientific program. Faculty lead sessions on thyroid career tracks, how to set up a thyroid practice and how to navigate the publication process and submit publication-ready articles.

A grant program is available for 15th ITC trainee attendees who qualify. The ATA Trainees’ Grant is a space limited opportunity open to trainees, fellows, residents, and medical and graduate students who are first authors on an accepted 15th International Thyroid Congress abstract until the program reaches capacity. Grant program details and instructions along with the trainee conference agenda are available on the 15th ITC website at www.ITC2015.thyroid.org. 15th International Thyroid Congress